Cantitate/Preț
Produs

Prescription Drugs: A Reference Handbook: Contemporary World Issues

Autor David E. Newton
en Limba Engleză Hardback – 11 noi 2021 – vârsta până la 17 ani
Prescription drugs are a basic and invaluable part of society today, but there is debate surrounding the methods of testing new drugs, the possible misuse of prescription drugs, and the economics of drug production and use.This book examines the evolution of prescription drugs in the United States, as well as the formation of the pharmaceutical industry. It begins with a history of prescription drugs, dating back to their origins, then moves through the Industrial Revolution and into the present day. It also delves into the issues and controversies related to prescription drugs, such as drug costs, regulations, prescription drug abuse, insurance complications, and more. Both implemented and proposed solutions are also discussed. One of the most valuable aspects of the book is that it surveys the history of prescription drugs in a manner that helps the reader identify key issues in an easy-to-understand fashion. Finally, the perspectives chapter allows a broad range of voices to be heard, allowing crucial, diverse perspectives to round out the author's expertise.
Citește tot Restrânge

Din seria Contemporary World Issues

Preț: 25237 lei

Nou

Puncte Express: 379

Preț estimativ în valută:
4830 5065$ 4027£

Carte tipărită la comandă

Livrare economică 08-22 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781440877728
ISBN-10: 1440877726
Pagini: 360
Ilustrații: 7 bw illus
Dimensiuni: 152 x 229 mm
Greutate: 0.64 kg
Editura: Bloomsbury Publishing
Colecția ABC-CLIO
Seria Contemporary World Issues

Locul publicării:New York, United States

Caracteristici

Introduces a detailed review of the steps involved in the preclinical, clinical, and post-clinical stages of testing of a new prescription drug

Notă biografică

David E. Newton holds a BA in chemistry, an MA in education from the University of Michigan, and an EdD in science education from Harvard University.

Cuprins

Preface,1 Background and History,Drug Basics,Drug Sources,Drug Types,Drug Nomenclature,The Drug Approval Process,Preclinical Testing,Clinical Testing,FDA Approval,Unapproved Drugs,Orphan Drugs,Prescription Drugs in History,The History of Pharmaceutics,Narcotics,Opiates,Semi-Synthetic Opioids,Synthetic Opioids,Monitoring of Drug Use,Conclusion,References,2 Problems, Controversies, and Solutions,Testing New Drugs,Animal Experimentation,Human Experimentation,Testing Biases,Reforming Drug Trial Inequities,Prescription Drug Abuse,Types of Prescription Drugs of Abuse,Stimulants,CNS Depressants,Opioids,The Cost of Prescription Drugs,The Data,Causes,Corporate Expenses and Profits,Other Causes,Possible Solutions,Conclusion,References,3 Perspectives,Introduction,The Cork Board,Kyle Citrin, Clay Knibbs, and Carter SoboleskiClimate Change and Prescription Drugs: The Impacts of Increased Temperature on Public Health,Shel EvergreenDrug Discovery: A Twentieth-Century Story of Scientific Curiosity, Persistence, and Creative Guesswork,Margaret Willig CraneWill Naloxone Become a Real "Superhero"?,Randolph FillmoreDrugs and the Professional Bodybuilder,Kenzie GauckThe Significance of Statistics,Joel GrossmanPrescription Drug Ads That Target Consumers,Phill JonesThe Human Brain,Maia PujaraThe Second-Best Time,Thomm QuackenbushSick Full Time,Marissa QuenquaThe Drug Supply Chain and the United States,Bob RoehrCan Information Technology Help Curb Prescription Drug Abuse?,Jeremy Summers4 Profiles,Alliance for Safe Online Pharmacies,Bayer AG,Drug Enforcement Administration,Carl Durham (1892-1974),Hubert Humphrey (1911-1978),Paul Janssen (1926-2003),Kaiser Family Foundation,William Proctor Jr. (1817-1874),Friedrich Sertürner (1783-1841),Alexander "Sasha" Shulgin (1925-2014),Daniel B. Smith (1792-1883),5 Data and Documents,Data,Table 5.1. Urban-Rural Differences in Drug Overdose Death Rates, by Sex, Age, and Type of Drugs Involved, 1999-2017,Table 5.2. Strategies Used by U.S. Adults to Reduce Cost of Prescription Drugs, 2013-2017,Table 5.3. Descriptive Statistics on Prescription Drug Prices for Select Countries, 2018,Table 5.4. Median Total Cost of Top-Selling Brand-Name Drugs, 2012-2017,Table 5.5. Prescription Drug Use in the Past 30 Days, by Sex, Race and Hispanic Origin, and Age: United States, Selected Years 1988-1994 through 2013-2016,Table 5.6. Trends in Use of One or More Prescription Drugs in the Past 30 Days, by Age, 2007-2016,Table 5.7. Most Commonly Used Prescription Drug Types in the Past 30 Days, by Age Group, 2015-2016,Documents,Durham-Humphrey Amendment (1951),Controlled Substances Act (1970),Orphan Drug Act of 1983,Drug Price Competition and Patent Term Restoration Act (1984),Prescription Drug Marketing Act of 1987,State Doctor Shopping Laws (1990/2011),Prescription Drug User Fee Act (1992),Animal Drug Availability Act (1996),Ryan Haight Online Pharmacy Consumer Protection Act of 2008,FDA Bad Ad Program (2010),United States ex rel. Michael Mullen v. AmerisourceBergen Corporation, et al. (2018),American Patients First (2018),Generic Drugs: Questions & Answers (2018),Association for Accessible Medicines v. Frosh (2018),Medicare Prescription Drug Coverage (2020),The American Hospital Association v. Azar (2020),6 Resources,Books,Articles,Reports,Internet,7 Chronology,Glossary,Index,